Skip to content
Open access · CC-BY via OpenAlex

RNA-Based Strategies for Cell Reprogramming toward Pluripotency

Anaëlle Bailly, Ollivier Milhavet, Jean-Marc Lemaître

Pharmaceutics · 2022 · ▲ 18 citations

Abstract

Cell therapy approaches to treat a wide range of pathologies have greatly benefited from cell reprogramming techniques that allow the conversion of a somatic cell into a pluripotent cell. Many technological developments have been made since the initial major discovery of this biological process. Recently reprogramming methods based on the use of RNA have emerged and seem very promising. Thus, in this review we will focus on presenting the interest of such methods for cell reprogramming but also how these RNA-based strategies can be extended to eventually lead to medical applications to improve healthspan(definition) and longevity.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/pharmaceutics14020317
Canonical
link ↗
Fetched
2026-11-11 MST

Cite this

APA
Bailly, A., Milhavet, O., &amp; Lemaître, J. (2022). RNA-Based Strategies for Cell Reprogramming toward Pluripotency. <em>Pharmaceutics</em>. https://doi.org/10.3390/pharmaceutics14020317
Vancouver
Bailly A, Milhavet O, Lemaître J. RNA-Based Strategies for Cell Reprogramming toward Pluripotency. Pharmaceutics. 2022. doi:10.3390/pharmaceutics14020317.
BibTeX
@article{analle2022RNABas, title = {RNA-Based Strategies for Cell Reprogramming toward Pluripotency}, author = {Anaëlle Bailly and Ollivier Milhavet and Jean-Marc Lemaître}, journal = {Pharmaceutics}, year = {2022}, doi = {10.3390/pharmaceutics14020317}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings